CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, colony formation and self-renewal of BP-CML but not cord blood CD34+ cells were completely abolished when they were treated with a combination of dasatinib and pyrvinium (Figures 2b–2c and Supplemental Tables 3-4).